Table 4. Changes in the levels of 7 parameters in the neoadjuvant chemotherapy group.
Neoadjuvant chemotherapy group | Prechemotherapy | Prior to the last cycle of chemotherapy | 6 m after chemotherapy | |
---|---|---|---|---|
TC | Mean±SD | 5.14±1.08 | 5.34±1.13 | 5.19±1.20 |
TG | Mean±SD | 1.42±0.78 | 1.97±1.02* | 1.86±0.83* |
LDL-C | Mean±SD | 2.82±0.78 | 3.14±0.82* | 2.92±0.88 |
HDL-C | Mean±SD | 1.33±0.31 | 1.17±0.24 | 1.33±0.28 |
HCY | Mean±SD | 11.44±9.46 | 9.65±2.57 | 10.56±2.45 |
UA | Mean±SD | 270.78±59.44 | 274.28±62.22 | 301.06±60.66* |
BMI | Mean±SD | 23.07±3.04 | 23.16±2.87 | 23.22±2.88 |
TC: total cholesterol (mmol/L); TG: triglycerides (mmol/L); LDL-C: low-density lipoprotein cholesterol (mmol/L); HDL-C: high-density lipoprotein cholesterol (mmol/L); HCY: homocysteine (μmol/L); UA: uric acid (μmol/L); BMI: body mass index; 6 m: 6 months; SD: standard deviation
* P<0.05 compared with the baseline level (prechemotherapy level)